AVAX TECHNOLOGIES INC
10QSB, EX-27, 2000-08-14
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: AVAX TECHNOLOGIES INC, 10QSB, EX-11.1, 2000-08-14
Next: AMF BOWLING WORLDWIDE INC, 10-Q, 2000-08-14



<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
    This schedule contains summary financial information extracted from
Electronic Processing, Inc. Statement of Income for year and six months ended
December 31, 1999 and June 30, 2000, respectively, and Balance Sheet as of
December 31, 1999 and June 30, 2000, and is qualified in its entirety by
reference to such financial statements.
</LEGEND>


<S>                                  <C>                     <C>
<PERIOD-TYPE>                               12-MOS                   6-MOS
<FISCAL-YEAR-END>                      DEC-31-1999             DEC-31-2000
<PERIOD-START>                         JAN-01-1999             JAN-01-2000
<PERIOD-END>                           DEC-31-1999             JUN-30-2000
<CASH>                                   3,426,059               8,031,145
<SECURITIES>                             8,868,621              25,236,815
<RECEIVABLES>                                    0                       0
<ALLOWANCES>                                     0                       0
<INVENTORY>                                      0                       0
<CURRENT-ASSETS>                        12,631,501              33,618,054
<PP&E>                                   2,458,678               2,776,841
<DEPRECIATION>                             116,862                 293,823
<TOTAL-ASSETS>                          14,973,317              36,550,983
<CURRENT-LIABILITIES>                      401,263                 798,835
<BONDS>                                          0                       0
                            0                       0
                                  1,752                     936
<COMMON>                                    44,311                  62,089
<OTHER-SE>                              14,023,650              34,344,050
<TOTAL-LIABILITY-AND-EQUITY>            14,973,317              36,550,983
<SALES>                                          0                       0
<TOTAL-REVENUES>                                 0                       0
<CGS>                                            0                       0
<TOTAL-COSTS>                            8,551,973               5,562,918
<OTHER-EXPENSES>                                 0                       0
<LOSS-PROVISION>                                 0                       0
<INTEREST-EXPENSE>                               0                       0
<INCOME-PRETAX>                         (7,867,563)             (4,653,819)
<INCOME-TAX>                                     0                       0
<INCOME-CONTINUING>                     (7,867,563)             (4,653,819)
<DISCONTINUED>                                   0                       0
<EXTRAORDINARY>                                  0                       0
<CHANGES>                                        0                       0
<NET-INCOME>                            (7,867,563)<F1>         (4,653,819)<F1>
<EPS-BASIC>                                   (.74)                   (.32)
<EPS-DILUTED>                                    0                       0


<FN>
(1) EPS-BASIC
</FN>


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission